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Abstract: Withania somnifera, commonly known as Ashwagandha, is an important 
medicinal plant that has been used in Ayurvedic and indigenous medicine for over 3,000 
years. In view of its varied therapeutic potential, it has also been the subject of 
considerable modern scientific attention. The major chemical constituents of the Withania 
genus, the withanolides, are a group of naturally occurring C28-steroidal lactone 
triterpenoids built on an intact or rearranged ergostane framework, in which C-22 and C-26 
are appropriately oxidized to form a six-membered lactone ring. In recent years, numerous 
pharmacological investigations have been carried out into the components of W. somnifera 
extracts. We present here an overview of the chemical structures of triterpenoid 
components and their biological activity, focusing on two novel activities, tumor inhibition 
and antiangiogenic properties of withaferin A and the effects of withanolide A on 
Alzheimer's disease. The most recent attempts in biotechnological production of 
withanolides are also discussed. 
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Introduction 
The Solanaceae family is comprised of 84 genera that include about 3,000 species, scattered 
throughout the world. Members of this family are generally annual shrubs. The genera Withania and 
Physalis play an important role in the indigenous medicine of South East Asia, e.g. in the Unani and 
Ayurvedic systems. The twenty-three known Withania species are widely distributed in the drier parts 
of tropical and subtropical zones, ranging from the Canary Islands, the Mediterranean region and 
northern Africa to Southwest Asia [1-4]. Among them, only two species, W. somnifera and W. 
coagulans, are economically and medicinally significant, being used and cultivated in several  
regions [5-7].  
W. somnifera, commonly known as Ashwagandha, is an important medicinal plant that has been 
used in Ayurvedic and indigenous medicine for over 3,000 years [8]. In view of its varied therapeutic 
potential, it has also been the subject of considerable modern scientific attention. Ashwagandha roots 
are a constituent of over 200 formulations in Ayruvedha, Siddha and Unani medicine, which are used 
in the treatment of various physiological disorders [9, 10]. Withania appears in WHO monographs on 
Selected Medicinal Plants and an American Herbal Pharmacopoeia monograph is also  
forthcoming [11]. 
In Ayurveda, Withania is widely claimed to have potent aphrodisiac, sedative, rejuvenative and life 
prolonging properties. It is also used as a general energy-enhancing tonic known as Medharasayana, 
which means ‘that which promotes learning and a good memory’ and in geriatric problems [12,13]. 
The plant was traditionally used to promote youthful vigor, endurance, strength, and health, nurturing 
the time elements of the body and increasing the production of vital fluids, muscle fat, blood, lymph, 
semen and cells. The similarity between these restorative properties and those of ginseng roots has led 
to Ashwagandha roots being called Indian ginseng [10]. It also helps counteract chronic fatigue, 
weakness, dehydration, bone weakness, loose teeth, thirst, impotency, premature ageing, emaciation, 
debility, and muscle tension. The leaves of the plant are bitter in taste and used as an antihelmantic. 
The infusion is given in fever. Bruised leaves and fruits are locally applied to tumors and tubercular 
glands, carbuncles and ulcers [12,14]. The roots are used as a nutrient and health restorative in 
pregnant women and old people. The decoction of the root boiled with milk and ghee is recommended 
for curing sterility in women. The roots are also used in constipation, senile debility, rheumatism, 
general debility, nervous exhaustion, loss of memory, loss of muscular energy and spermatorrhoea 
[10,15]. Today W. somnifera is widely cultivated in the drier parts of India (more than 4,000 ha) i.e. 
Manasa, Neemuch and Jawad tehsils of the Mandsaur District of Madhya Pradesh, Punjab, Sind and 
Rajastan [6,8].  
W. coagulans, common in Iran, Pakistan, Afghanistan and East India, is also used in folk medicine. 
Fruits of the plant have a milk-coagulating property attributed to the pulp and husk of the berry, which 
has been used in the preparation of vegetable rennet ferment for cheese [16]. In 1884 Sheridan Lea 
found upon examination that the coagulating substance is a ferment closely resembling animal rennet 
[17]. The milk-coagulating activity is due to the presence of an enzyme and, under optimum 
conditions, one part of concentrated enzyme can coagulate 90,000 parts of milk in half an hour [16]. 
The fruits are reported to be sedative, emetic, and stomachic, a blood-purifier and febrifuge, an 
alterative, diuretic, and bitter tonic in dyspepsia as well as a growth promoter in infants [15]. They are 
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also useful in chronic complaints of liver, and in the treatment of asthma and biliousness. The twigs 
are chewed to clean teeth and the smoke of the plant is inhaled to relieve toothache. The leaves are 
used as a vegetable and as fodder for livestock [12,18]. The crude preparation of the plant has been 
found to be active against a number of pathogenic bacteria [19]. 
W. somnifera (L.) Dunal (Synon. Physalis somnifera L.; Physalis flexuosa L.) is an erect, grayish, 
stellate-tomentose undershrub (30-75 cm high) with long tuberous roots. Leaves are alternate or sub-
opposite, broadly ovate to oblong, petiolate, sub-acute, entire, with lamina 5-10 x 2.5-7 cm. Flowers 
are small, greenish, axillary, solitary or in few-flowered cymes and bisexual. The calyx is 
gamosepalous with five 3-5 mm lobes, accrescent and inflated in a fruit. The corolla is campanulate, 
greenish-yellow with five 5-8 mm lobes. There are five included stamens. The ovary is ovoid/globose, 
glabrous, and many ovuled. The style is filiform and stigma is 2-lobed. Fruit is a globose berry, 
orange-red when ripe and enclosed in the enlarged calyx. Seeds are many, discoid, yellow and 
reniform. The chromosome number is 2n = 48 [1, 2, 20].  
Chemical constituents 
The chemistry of Withania species has been extensively studied and several groups of chemical 
constituents such as steroidal lactones, alkaloids, flavonoids, tannin etc. have been identified, 
extracted, and isolated [14,21-25]. At present, more than 12 alkaloids, 40 withanolides, and several 
sitoindosides (a withanolide containing a glucose molecule at carbon 27) have been isolated and 
reported from aerial parts, roots and berries of Withania species. The major chemical constituents of 
these plants, withanolides, are mainly localized in leaves, and their concentration usually ranges from 
0.001 to 0.5% dry weight (DW) [14,26,27]. The withanolides are a group of naturally occurring C28-
steroidal lactones built on an intact or rearranged ergostane framework, in which C-22 and C-26 are 
appropriately oxidized to form a six-membered lactone ring. The basic structure (Figure 1) is 
designated as the withanolide skeleton [28-32].  
Figure 1. The basic structure of withanolides.  
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The withanolide skeleton may be defined as a 22-hydroxyergostan-26-oic acid-26,22-lactone. There 
are many novel structural variants of withanolides with modifications either of the carbocyclic 
skeleton or the side chain and these have often been described as modified withanolides or ergostan-
type steroids related to withanolides. These compounds are generally polyoxygenated and it is 
believed that plants elaborating them possess an enzyme system capable of oxidizing all carbon atoms 
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in a steroid nucleus. The characteristic feature of withanolides and ergosane-type steroids is one C8 or 
C9-side chain with a lactone or lactol ring but the lactone ring may be either six-membered or five-
membered and may be fused with the carbocyclic part of the molecule through a carbon-carbon bond 
or through an oxygen bridge. Appropriate oxygen substituents may lead to bond scission, formation of 
new bonds, aromatization of rings and many other kinds of rearrangements resulting in compounds 
with novel structures [28,30,33].  
Withanolides are present in fifteen Solanaceous genera i.e. Acnistus, Datura, Deprea, Dunalis, 
Iochroma, Jaborosa, Lycium, Nicandra, Physalis, Salpichroa, Tubocapsicum, Discopodium, 
Trechonaetes, Withania and Witheringia. The occurrence of withanolides is not completely restricted 
to Solanaceous plants and reports of their isolation from marine organisms, and from members of the 
Taccaceae [34,35], Fabaceae (Leguminosae) [36] and Lamiaceae (Labiatae) [37] families suggest that 
they are much more widely distributed.  
Biosynthesis of withanolides 
The biosynthetic pathways of withanolides and other chemical constituents of W. somnifera are not 
fully known, and there is very little information about their biogenetic aspects [38-40]. It has been 
reported that, except for a very few exceptions, the plants that synthesize the 20-H withanolides are 
unable to produce the 20-OH counterparts and vice versa [38]. Since withanolides are probably 
derived from cholesterol, this is a pertinent starting point to discuss their biosynthesis. The first step in 
the biosynthesis of cholesterol is the activation of acetate by its conversion to acetyl Co-enzyme A, 
abbreviated as acetylCoA. Two units of acetylCoA are combined and metabolized to mevalonic acid. 
Only the R- form of mevalonic acid is used by the living system to produce terpenes, while the S- form 
is metabolically inert. The (R)-mevalonic acid is converted into isopentenyl pyrophosphate (IPP) 
through the loss of one carbon atom. The molecule of 3-isopentenyl pyrophosphate (IPP) can condense 
in a head-to-tail manner with its isomer, 3,3-dimethyl allyl pyrophosphate (DMAPP), to give geranyl 
pyrophosphate (GPP). A condensation reaction of trans geranyl pyrophosphate with another molecule 
of IPP yields farnesyl pyrophosphate (FPP). The enzyme squalene synthase catalyses the condensation 
of two molecules of farnesyl pyrophosphate in a head-to-head manner in the presence of NADPH to 
produce squalene. Oxidation of squalene by atmospheric oxygen is catalyzed by NADPH-linked oxide 
to afford squalene 2,3-epoxide. The latter undergoes ring closure to form lanosterol which is then 
converted into a variety of different steroidal triterpenoidal skeletons. The bioconversion of lanosterol 
to 24-methylenecholesterol is still not fully understood. The sequence of reactions and intermediates 
may also differ slightly among organisms. 24-Methylenecholestrol may be a biosynthetic precursor of 
steroidal lactones. It has been proposed that the hydroxylation in C22 and δ-lactonization between C22 
and C26 of 24-methylenecholestrol yields withanolides (see Figure 2). It has also been suggested that 
the α,β-unsaturated ketone in ring A of common withanolides may be produced through the sequence 
20-23 [41-43]. 
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Figure 2. Overview of the most important steps in the withanolide biosynthetic pathway. 
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Figure 2. Cont. 
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Withaferin A (4β,27-dihydroxy-1-oxo-5β,6β-epoxywitha-2-24-dienolide, Figure 3) was the first 
member of this group of compounds to be isolated from the well-known South-Asian medicinal plant, 
W. somnifera. The structural novelty and interesting biological activities elicited by this compound led 
to a thorough chemical investigation of the plant and numerous compounds with similar structural 
features were isolated [28,30,36].  
Figure 3. Structure of withaferin A. 
O
O O
O
OH
OH  
Lavie’s group [44] elucidated the structure of withaferin A in leaves of this plant, which is mainly 
valued for its anti-cancerous properties. The yields of withaferin A from intact plants of Withania spp. 
(Israel Chemotype) are 0.2-0.3% of DW of leaves [45]. Gupta et al. [46] have performed a quantitative 
analysis of Indian chemotypes of W. somnifera by TLC densitometry and observed that withaferin A is 
totally absent in roots, stems, seeds and persistent calyx of fruits of intact plants but present in leaves 
(1.6%). Today over 130 withanolides from Solanaceae genera are known, mostly occurring in free 
form, but in a few cases also as glycosides [28], some of which are shown in Figure 4. 
 
Figure 4. Different structures of withanolides. 
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Withaferin A R1=OH, R2=H, R3=H; Withanolide D R1=H, R2=OH, R3=H; 27-Deoxywithaferin A R1=H, 
R2=H, R3=H; 14α-OH, R1=H, R2=H; 17α-OH, R1=H, R2=H, R3=H; 27-Hydroxywithanolide D R1=OH, 
R2=OH, R3=H; 14α-OH, R1=OH, R2=H, R3=H; 17α-OH, R1=OH, R2=H, R3=H; Dihydrodeoxywithaferin A 
2,3-diH, R1=H, R2=H, R3=H; Dihydrowithaferin A 2,3-diH, R1=H, R2=OH, R3=H; 17-Hydroxywithaferin A, 
R1= R3=OH, R2=H. 
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Figure 4. Cont. 
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Withanolide E 5β, 6β-epoxy; Withanolide F Δ5; Withanolide S 5α-OH, 6β-OH. 
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Figure 4. Cont. 
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Withanone 17α-OH, R1=H, R2=H; Withanolide T 14α-OH, 17α-OH, R1=OH; Withanolide B R1=H, R2=H; 
Withanolide A R1=OH, R2=H. 
Other compounds 
Examination of W. somnifera roots has resulted in the isolation of a new dimeric thiowithanolide, 
named ashwagandhanolide (Figure 5) [47]. A bioassay-guided purification of the methanolic extract of 
W. somnifera fruits yielded withanamides A-I (Figure 6). The structure of these compounds was 
determined by using serotonin, glucose and long-chain hydroxyl fatty acid moieties [48].  
In their quantitative analysis of Indian chemotypes of W. somnifera by TLC densitometry, Gupta et 
al. [46] detected alkaloids in all the abovementioned plant parts, with the highest content found in 
leaves. This is in contrast to the general belief that tropane alkaloids are restricted to the roots of 
Withania spp. Extraction with 45% alcohol yields the highest percentage of alkaloids. The isolation of 
nicotine, somniferine, somniferinine, withanine, withananine, pseudowithanine, tropine, 
pseudotropine, 3α-tigloyloxytropane, choline, cuscohygrine, dl-isopelletierine and new alkaloids 
anaferine and anhygrine has been described [14,49]. The reported total alkaloid content in the roots of 
Indian W. somnifera varies between 0.13 and 0.31%, though much higher yields (up to 4.3%) have 
been recorded in plants of other regions/countries. In addition to the alkaloids, the roots are reported to 
contain starch, reducing sugars, hentriacontane, glycosides, dulcitol, withanicil, an acid and a neutral 
compound. The leaves are reported to contain five unidentified alkaloids (yield 0.09%), chlorogenic 
acid, calystegines (nitrogen-containing polyhydroxylated heterocyclic compounds) withanone, 
condensed tannin and flavonoids. The berries have amino acids. Four types of peroxidases have been 
purified and characterized from W. somnifera roots [14,50]. 
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Figure 5. Ashwagandhanolide, a new compound isolated from W. somnifera. 
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Figure 6. Different withanamides (A-I) isolated from W. somnifera fruits. 
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Figure 6. Cont. 
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Pharmacological activities of withanolides 
The pharmacological activity of W. somnifera extracts has been summarized recently by Gupta and 
Rana [49]. Historically, W. somnifera has been used as an antioxidant, adaptogen, aphrodisiac, liver 
tonic, antiinflamatory agent and astringent and more recently as an antibacterial, antihyperplycemic 
and antitumoral, as well as to treat ulcers and senile dementia.  
The active principles of W. somnifera have been tested for antioxidant activity by observing the 
levels of the major free-radical scavenging enzymes, superoxide dismutase, catalase and glutathione 
peroxidase, in the rat brain frontal cortex and striatum. The increase in these enzymes after treatment 
with withanolides represent enhanced antioxidant activity and a corresponding protective effect on 
neuronal tissue, suggesting that the antioxidant effect of W. somnifera in the brain may be responsible 
for its diverse pharmacological properties [51]. Similarly, oral administration of W. somnifera extracts 
prevented an increase in lipid peroxidation in mice and rabbits [52].  
Anxiolitic and antidepressant actions of the bioactive withanolides have been assessed in rats [53]. 
Withanolides reduced rat brain levels of tribulin (an endocoid marker of anxiety) when the levels of 
this compound were increased by administration of pentylenetetrazole, an anxiogenic agent. The 
antidepressant effect of withanolides is comparable with that induced by imipramine in the forced 
swim-induced “behavioural despair” and “learned helpessness” test. In a rat model withanolides were 
able to decrease the number and severity of chronic stress-induced ulcers, reverse chronic stress-
induced inhibition of male sexual behavior, chronic stress-induced immunosuppression and also 
increased peritoneal macrophage activity [54]. It has also been demonstrated that methanolic extracts 
of Withania reduce ulcer index, volume of gastric secretion, free acidity, and total acidity [55].  
The effects of sitoindosides VII-X and withaferin isolated from aqueous methanol extracts of  
W. somnifera roots were studied on brain cholinergic, glutamatergic and GABAergic receptors in rats. 
The data suggest the bioactive compounds preferentially influence events in the cortical and basal 
forebrain cholinergic-signal transduction cascade. The cognition-enhancing and memory-improving 
effects of W. somnifera extracts can be partly explained by the drug-induced enhancement of cortical 
muscarinic acetylcholine receptor capacity [56]. In general, Ashawagandha has been used traditionally 
and commonly as a tonic and nootropic agent. It has also been associated with improvements in 
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scopolamine-induced memory deficits in mice [57]. Methanolic extracts of the plant have been 
reported to induce neurite extension [58] and to contain withanolides such as withanolide A, 
withanoside IV and withanoside VI, which induce neurite outgrowth in human neuroblastome SH-
SY5Y [59]. In Aβ(25-35)-induced damaged cortical neurons, withanolide A, withanoside IV and 
withanoside VI showed neuritic regeneration and synaptic reconstruction. Dentritic atrophy was 
completely prevented by treatment with these withanolides, particularly withanoside IV and VI [60].  
Neuroleptic-induced catalepsy has been used as an animal model for screening drugs for 
Parkinson’s disease. Hope of treatment for this disease has been offered by the inhibitory effects of W. 
somnifera extracts on haloperidol or reserpine-induced catalepsy in mice [61]. The antiparkinsonian 
effect of W. somnifera extracts has also been attributed to potent antioxidant, antiperoxidative and free 
radical quenching properties [62].  
The extracts of W. somnifera have shown antiinflamatory effects in a variety of rheumatological 
conditions, reducing, for example, Freund’s complete adjuvant-induced inflammation in rats and 
decreasing to undetectable levels the α2-glycoprotein found only in inflamed rat serum [63]. In 
another study, W. somnifera caused suppression of a2-macroglobulin, an indicator for antiinflamatory 
drugs in rat serum inflamed by injection of carrageenan suspension [64]. The extracts also caused a 
significant reduction in both paw swelling and bony degenerative changes in Freund’s adjuvant-
induced arthritis as observed by radiological examination [65]. Rats injected with formaline in the hind 
leg footpad showed decreased absorption of 14C-glucose in rat jejunum, glucose absorption being 
maintained at the normal level by Withania extracts, which produced an antiinflamatory effect [66].  
The traditional antihyperglycemic and antidyslipidemic activities of W. coagulans, popularly 
known as Indian cheese marker, have been recently confirmed [67]. Withanolides isolated from W. 
coagulans fruits show significant inhibition of the postprandial rise in hyperglycemia post-sucrose 
load in normoglycemic rats as well as streptozocin-induced diabetic rats. 
W. somnifera extracts have a chemopreventive effect on skin cancer in mice induced by 7,12-
dimethylbenz[a]antracene. This activity is thought to be partly due to the antioxidant/free radical 
scavenging activity of the extract [68]. Recently, bioactive properties of withaferin A have been 
reported: cytoskeletal architecture alteration by covalently binding annexin II [69], antitumor capacity 
by inhibition of proteasomal chymotrypsin-like activity [70], and apoptosis induction through the 
inhibition of protein kinase C [71]. In relation to the apoptosis-inducing mechanism of withaferin A, 
Oh et al. [72] have demonstrated that it is associated with the activation of caspase-3 and the 
translocation of cytochrome c from the mitochondria to the cytosol, as well as the cleavage of PLC-γ1 
(a substrate protein of caspases), whereas ectopic expression of Bcl-2 oncoprotein significantly 
attenuates withaferin A-induced apoptosis.  
Withania alkaloids have a prolonged hypotensive, bradycardic and respiratory-stimulant action in 
dogs [73]. It has been found that the hypotensive effect is mainly due to autonomic ganglion blocking 
action as well as a depressant action on the higher cerebral centers. The alkaloid stimulates the 
vasomotor and respiratory centers in the brain stem of the dogs. The cardio-inhibitory action appeared 
to be due to ganglion blocking and direct cardio-depressant actions.  
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A biotechnological approach to withanolide production 
Many biotechnological studies of Withania species, especially W. somnifera, have been carried out 
to enhance the production of their active compounds. Large-scale plant cell cultures may be cost-
effective and also allow the production of higher amounts of withanolides in a relatively short period 
of time.  
Tissue cultures of an Indian chemotype of W. somnifera from axillary meristems using MS agar 
medium supplemented with 2,4-D, IAA, NAA, BA, coconut milk or kinetin, either alone or in 
combination, have been reported [74]. Calli were formed on medium containing 2.0 mg 2,4-D/L and 
0.2 mg Kin/L. Suspension cultures were initiated from callus tissue in liquid MS medium 
supplemented with 2.0 mg 2,4-D/L, 0.2 mg Kin/L and 2.0 mg BA/L. Multiple shoot cultures were also 
grown in MS agar medium containing 2.0 mg BA/L. Callus cultures failed to synthesize withanolides, 
but multiple shoot cultures synthesized significant amounts; their concentrations were highest with 2.0 
mg BA/L and 10% coconut milk. Multiple shoot cultures of W. somnifera from single shoot tip 
explants and their potential for the production of withaferin A and withanolide D have also been 
investigated [75]. Shoot tips grown on MS medium supplemented with BA (1 mg/l) induced 10.0 
microshoots per explant and shoot cultures accumulated withaferin A (0.04 %) and withanolide D 
(0.06%). Supplementation of MS solid agar medium with 1.0 mg BA/L and 4% sucrose enhanced 
accumulation of both withaferin A (0.16%) and withanolide D (0.08 %). MS liquid medium containing 
1.0 mg BA/L and 10% coconut milk favoured a maximum increase in biomass (27 fold), induced 
microshoots (37.6) as well as accumulation of withaferin A (0.14%). 
Direct rooting from leaf explants of W. somnifera has been achieved on half-strength MS medium 
supplemented with 15 g/l sucrose, and different concentrations of growth regulators [76]. The roots 
were cultured on MS liquid medium for the establishment of root-organ cultures with the same plant 
growth regulators and incubated on an orbital shaker at 80 rpm at 25±2 ◦C. The concentration of 
alkaloids increased compared to field grown roots. The maximum concentration of withanolides  
(10 mg/g dry weight) was obtained in the bioreactor. Recently, withanolide A biogeneration in shoot 
cultures of W. somnifera has been reported [77]. Multiple shoot cultures of two experimental lines of 
W. somnifera were established using nodal segments as explants. The hormonal combinations of 
benzyl adenine and kinetin influenced morphogenetic response as well as differentially modulating the 
level of biogeneration of withanolide A in the in vitro shoots of the two lines. The production of 
withanolide A in the cultures varied considerably (ca. 10-fold, 0.014 to 0.14 mg/g fresh weight) 
according to the hormone composition of the culture media as well as the genotype used as the explant 
source.  The shoot culture of experimental lines cultivated at 1.0 ppm of BAP and 0.5 ppm of kinetin 
displayed the highest concentration of withanolide A in the green shoots of 0.238 %.  
Hairy root cultures as a source of withanolides 
In the two last decades, the hairy root system based on Agrobacterium rhizogenes inoculation has 
become popular as a method of producing secondary metabolites synthesized in plant roots [78-79]. 
Unorganized plant tissue cultures are frequently unable to produce secondary metabolites at the same 
levels as the intact plant. The hairy root phenotype is characterized by fast, hormone-independent 
growth, lack of geotropism, lateral branching and genetic stability. The secondary metabolites 
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produced by hairy roots arising from the infection of plant material by A. rhizogenes are the same as 
those usually synthesized in intact parent roots, with similar or higher yields [80]. This feature, 
together with genetic stability and generally rapid growth in simple media without phytohormones, 
makes them especially suitable for biochemical studies not easily undertaken with root cultures of an 
intact plant. Banerjee et al. [81] carried out hairy root transformation of W. somnifera by three 
different strains of A. rhizogenes (A4, LBA 9402 and LBA 9360) and analyzed the specificity and 
frequency of their withanolide production with special reference to withaferin A. The best response in 
terms of transformation ability and growth of the hairy roots was obtained with strain A4, followed by 
LBA 9402; LBA 9360 failed to induce a transformation event. The production of withaferin A was 
studied in the A4-induced hairy root lines at different growth phases (4, 10 and 24 weeks) using HPLC 
(high performance liquid chromatography) and maximum levels were observed in the media and hairy 
roots of 10-week-old cultures. During the infection process A. rhizogenes transfers a part of the DNA 
(transferred DNA, T-DNA) located in the root-inducing plasmid Ri to plant cells and the genes 
contained in this segment are expressed in the same way as the endogenous genes of the plant cells 
[82]. Some A. rhizogenes, such as strain A4, have the T-DNA divided in two sections, the TR-DNA 
and TL-DNA, each of which can be incorporated separately into the plant genome. Two sets of pRi 
genes are involved in the root induction process: the aux genes located in the TR region of the pRi T-
DNA and the rol (root loci) genes of the TL region [83]. The ags genes responsible for opine 
biosynthesis in the transformed tissues are also located in the TR region [84]. Opines are synthesized 
by plant transformed cells and are only used by Agrobacterium as a source of nitrogen and carbon. 
Due to the similarities between the A. rhizogenes and A. tumefaciens infection processes, and because 
both microorganisms are very closely related, it has been suggested that the most important A. 
rhizogenes oncogenes encode proteins involved in the regulation of plant hormone metabolism. 
Transformation of W. somnifera with wild type nopaline and octopine strains of A. tumefaciens has 
been reported [75]. The oncogenic strains showed different levels of virulence in the two genotypes 
studied, the main difference being found in the nature of the galls formed and in their subsequent 
morphological competence. Ten percent of the galls obtained after infection with nopaline strain N2:73 
spontaneously developed shooty teratomas of altered phenotype. The shooty teratomas grew in 
unsupplemented basal medium and were able to synthesize both major withanolides of the parent 
plants. Withanolide synthesis in shooty teratomas was much higher (0.07–0.1% withaferin A and 
0.085–0.025% withanolide D) than in non-transformed shoot cultures.  
Aux genes provide transformed cells with an additional source of auxin [85,86], but they do not 
seem essential for developing hairy root disease [79]. However, rol genes have functions that are most 
likely other than that of producing mere alterations in plant hormone concentrations [87].  Several 
authors have investigated the effect of TR and TL regions of A. rhizogenes on the growth and 
morphology of transformed roots and plants, but until now there have been few studies on the direct 
effects of oncogenes on secondary metabolism. As previously reported, a correlation exists between 
the expression of the rolC gene and the production of tropane alkaloids [88-90], Catharanthus roseus 
alkaloids [91], and ginsenosides [92]. No correlation between rolA and rolB expression and secondary 
metabolism was found in any of these studies. Moyano et al. [93] showed that the inoculation of leaf 
sections of tobacco, Duboisia hybrid and Datura metel plants with the A4 strain of A. rhizogenes 
induced transformed roots with the capacity to produce putrescine-derived alkaloids such as nicotine, 
Molecules 2009, 14                            
 
 
2387
hyoscyamine and scopolamine. The obtained hairy roots generally presented two morphologies: 
typical hairy roots with a high alkaloid-producing capacity, and callus-like roots with faster growth 
and lower alkaloid production. The aux1 gene of A. rhizogenes located in the TR-DNA of A. 
rhizogenes was detected in all roots showing callus-like morphology, but only in 25-60% of the 
established root cultures showing typical hairy morphology. These results demonstrate a significant 
role of aux genes in the morphology of transformed roots and the importance of typical hairy root 
morphology in the production of scopolamine. The studies with Panax ginseng hairy roots also support 
the effects of the genes located in the TR-DNA on root morphology and secondary metabolism [94]. 
Bandyopadhyay et al. [25] have reported the presence of TR-DNA in all the transformed callus lines 
of W. somnifera obtained after infection with A. rhizogenes A4, thus confirming the effects of aux 
genes on root line phenotypes. Recently, Mirjalili et al. [95] showed that the inoculation of leaf 
sections of W. coagulans with A. tumefaciens strain C58C1 (pRiA4) induced transformed roots with 
two morphologies: callus-like roots (CR) with a high capacity to produce withanolides and typical 
hairy roots (HR) with faster growth capacity and lower withanolide accumulation. The presence of the 
aux1 gene has been confirmed in 100% of the root lines displaying callus-like morphology, but in only 
12.5% of roots with typical hairy root morphology. 
Withanolide composition and in vitro culture of an Italian chemotype of W. somnifera have been 
reported [96]. Withanolide production by in vitro cultures (callus, shoots, leaves and roots transformed 
by A. rhizogenes, derived from the Sicilian plant) was investigated on MS media either supplemented 
with BA or 2,4-D, or without any plant growth regulators. Limited production was observed in shoot 
and callus cultures and no withanolides were detected in hairy roots. Withanolide production by hairy 
root cultures of W. somnifera transformed with A. rhizogenes (LBA 9402) has also been reported [97]. 
Hairy roots grew on MS medium containing 3% (w/v) sucrose in the absence of exogenous plant 
growth regulators. Root cultures synthesized several withanolides, from which withanolide D was 
isolated and identified. The productivity of withanolide D in transformed roots (0.181 mg/L) was 
higher than in untransformed root cultures (daily production of 0.181 and 0.026 mg/L, respectively).  
Developmental variability and withanolide production were introduced into W. somnifera using 
genetic transformation by different strains of A. rhizogenes. After inoculation, typical transformed root 
lines, transformed callus lines, and rooty callus lines were produced and their growth rates and 
withasteroid accumulation were studied. Accumulation of withaferin A was maximum (0.44% dry 
weight) in the transformed hairy root lines. All the rooty callus lines accumulated both withaferin A 
and withanolide D. Some of the callus lines produced both withaferin A (0.15–0.21% dry weight) and 
withanolide D (0.08–0.11% dry weight), and they grew faster than the transformed root lines [25].  
 
Conclusions 
 
By applying novel study concepts and objective scientific analysis, drugs used in traditional 
medicine may be a rich source of new medicines to treat intractable diseases. In this context, 
Aswagandha, chemically rich with its varied content of active compounds, such as withanolidess, 
sitoindosides and many useful alkaloids, and used for centuries to treat a wide range of diseases, 
constitutes a promising candidate as a multi-purpose medicinal agent.  However, more clinical trials 
need to be carried out to support its therapeutic use.  For example, although the high potential of 
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withanolide A for neuronal regeneration is well-known, it would be dangerous to simply imply that 
this compound could be an excellent anti-dementia drug. It would first be necessary to investigate the 
side effects of the bioactive compounds and their possible interactions, and to develop more clinical 
experiments.  
Nevertheless, Withania active components have promising activities, and biotechnological 
production could offer an alternative to conventional cultivation. Several laboratories have recently 
developed plant cell and hairy root cultures for the production of the most important bioactive 
components of Withania extracts, withaferin A and withanolide A. Although withanolide production 
by in vitro cultures is still far from the levels required for economical exploitation, these studies are 
useful tools to obtain greater understanding of the withanolide metabolic pathway, allowing the 
application of plant metabolic engineering techniques to improve the biotechnological production of 
Withania bioactive compounds.    
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